Drug policy fellow Katharine A. Neill explains why establishing heroin-assisted treatment programs, which provide severely addicted individuals with controlled access to pharmaceutical-grade heroin, could make a significant dent in the number of U.S. deaths from opioid use in this post for the Baker Institute Blog.
Understood in its regional context, Philippines President Rodrigo Duterte’s war on drugs appears to be a continuation rather than a departure from Southeast Asian drug policy.
Katharine Neill, the Alfred C. Glassell, III Postdoctoral Fellow in Drug Policy, explains what you should know about the Justice Department's plan to release 6,000 nonviolent drug offenders from federal prison during four days in October and November.
A new White House initiative to address rising U.S. heroin use will increase funds to pinpoint the sources of heroin as well as hot spots for drug overdoses. Baker Institute Blog: http://bit.ly/1h0W7r2
Asthma in children costs an estimated $27 billion annually for doctor visits, emergency department visits and hospitalizations. Not surprisingly, kids with asthma miss more days of school and do worse academically. The first step to the management and treatment of asthma is access to a primary care provider who can prescribe the necessary medications and develop an asthma action plan. However, if we want to have a significant impact on the negative consequences of this disease on our children, a multi-faceted approach that includes policy is an absolute must.
Drug policy has experienced an interesting shift recently. Along with legalization of medical and recreational marijuana, many states are also reducing penalties for nonviolent drug offenses and placing greater focus on treatment for drug users. The emphasis on treatment and rehabilitation for drug users is the result of many factors, including recognition that the drug war has not reduced drug use, a desire to reduce the prison population and save money, and a surge in the rate of overdoses from opioid and heroin use. What remains to be seen is whether the current popularity of drug treatment will become a more permanent feature of drug policy. In this Baker Institute Viewpoints series, five experts on drug policy examine the question, “Is the current emphasis on treatment in drug policy a short-term trend or is it here to stay?”
Katharine Neill Harris, William MartinDecember 19, 2014
In this Baker Institute Viewpoints series, five experts on the marijuana industry examine the question, “What does the future hold for the cannabis industry, in Texas and beyond?”
In the current campaign for Harris County district attorney, both incumbent D.A. Devon Anderson and challenger Kim Ogg have not only proposed to change the way marijuana use is handled by that office, but have also made the issue a centerpiece of their campaigns. Drug policy fellow Katharine Neill examines each candidate’s proposed changes in a new Baker Institute Blog.
